Thursday, 3 July 2008

Mental Test Spots Alzheimer's Risk

Interesting article well worth reading.

The Everyday Cognition instrument consists of 39 questions to be answered by people who know the patient well.



Mental Test Spots Alzheimer's Risk

A new questionnaire may help in both diagnosing older adults facing dementia and also in identifying individuals who need help with daily living.

The Everyday Cognition instrument consists of 39 questions to be answered by people who know the patient well.

"There have been a number of studies that show that people with mild cognitive impairment who have functional problems in addition to performing poorly on neuropsychological testing are more likely to progress in the near future," said study author Sarah Tomaszewski Farias, an assistant professor of neurology at the University of California, Davis, Medical Center in Sacramento. "One of our hopes is that this instrument will be able to help identify very early on those people at increased risk for developing Alzheimer's disease."

That would help both patients and family members prepare for what lies ahead and identify patients who need to be more closely monitored.

In addition, Farias said, the test would also help identify "people who are having [functional] problems so that we know who needs help and who doesn't."

"What's nice about this is that it is designed to pick up very early memory problems, and it's an entirely caregiver-based survey," said Dr. Scott Turner, incoming director of the Memory Disorders Program at Georgetown University Medical Center, in Washington, D.C. "This is something the caregiver can fill out, while the practitioner is looking at the patient. It could be used for screening, for diagnosis and for drug development, if you want to look for some proof that your drug is having some effect, so it has a lot of potential uses."

"They want something that they could use to ask a family member about the potential patient's everyday functioning to see if that's sensitive to picking up the likelihood of dementia early on," added Dr. Gary J. Kennedy, director of geriatric psychiatry at Montefiore Medical Center in New York City.

The findings were published in the July issue of Neuropsychology.

Existing neuropsychological tests tend to be very abstract. For the last 40 years, these tests have looked at two categories: so-called "basic" activities (such as grooming, feeding, dressing), which are affected in later stages of dementia, and "instrumental" activities of daily living (such as managing medication, finances, cooking, driving).

"I was interested in understanding how our neuropsychology tests translated into everyday problems, how our cognitive tests . . . translate into everyday problems that a person is experiencing and that a caregiver is concerned about," Farias explained.

Farias and her colleagues divided everyday functioning into seven cognitive "domains:" memory, language, semantic or factual knowledge, visual and spatial abilities, planning, organization and divided attention.

An original list of 138 items was eventually culled to 39, which was then tested in 576 older adults: 174 of whom were cognitively normal, 126 who had mild cognitive impairment (MCI), and 276 who had been diagnosed with dementia.

"Informants" (people who had known the patient for an average of almost 45 years) provided details on whether the patient could remember shopping items without a list, reading a map, balancing the checkbook, and cooking or working and talking at the same time.

Not only did the instrument confirm established diagnoses, it was also able to distinguish people with MCI from those with full-blown dementia, meaning it was able to pick up on subtle differences in function.

The results also weren't highly influenced by occupation and education levels, as are existing tests.

"This is really the first step in development the instrument," Farias said. "What we're really interested in doing is to track people over time to get a better understanding of the early signs of functional impairment."



Wednesday, 2 July 2008

Meditation, Yoga Might Switch Off Stress Genes

clipped from health.usnews.com

There's more on meditation at the U.S. National Center for Complementary and Alternative Medicine.

Relax! Stress, if Managed, Can Be Good For You


You're aiming for stimulated and focused—but not frazzled.


Healthful Lifestyle Teaches Prostate Genes to Behave

Living right—with a good diet, exercise, and low stress—brings out the best in your genes.


Audio: Dr. Dean Ornish on How Diet Affects Genes

 blog it

Grape seed extract may fight Alzheimer's

This is a second post on grape seed and MegaNatural AZ. If you want to look into this clip the link below.
A red grape seed
extract that packs the punch of red wine -- without the alcohol --
could help protect against memory loss due to Alzheimer's disease

Polyphenolic compounds are antioxidants naturally found in wine,
tea, chocolate, and some fruits and vegetables. The mice in the
study received levels of polyphenols equivalent to what a person
would consume with a daily glass or two of red wine.

To sidestep the alcohol issue, Pasinetti and his team
investigated whether an extract of red grape seeds sold as
MegaNatural AZ by Polyphenolics, a Madera, California-based grape
products supplier, might prevent the progress of the disease in
mice. Polyphenolics helped fund the research.

 blog it

News From The Journal Of Clinical Investigation


Overactivation of proteins known as calpains, which are involved in memory formation, has been linked to Alzheimer disease. Ottavio Arancio and colleagues, at Columbia University, New York, have now shown that two different drugs that inhibit calpains can improve memory in a mouse model of Alzheimer disease (APP/PS1 mice), leading them to suggest drugs that target calpains might stop or slow down the memory loss that occurs as Alzheimer disease progresses.

It is thought that dysfunctional signaling between nerve cells contributes to the impaired cognition experienced by individuals with Alzheimer disease.

AUTHOR CONTACT:
Ottavio Arancio

Columbia University, New York, New York, USA.

View the PDF of this article at: https://www.the-jci.org/article.php?id=34254
 blog it

Tuesday, 1 July 2008

Worried about your memory?

You can obtain this free booklet by clicking the link in the clip.

If you prefer paste this link into your browser.

http://tinyurl.com/46r8h4

Worried about your memory? Booklet
This booklet is designed to help you understand more about memory loss, so that if you are worried - either about your own or someone else's memory - you can seek advice and, if necessary, get treatment and support.

Worried about your memory poster
blog it

Lack of good HDL Cholesterol Linked to Memory Loss

If you are genetically predisposed to Alzheimer's by birth you might want to take a close look at this article and video.

My mother falls into this category so it does concern me.
clipped from health.usnews.com
News today that low levels of the "good" HDL cholesterol raises a person's risk of memory loss and memory loss and dementia may send many folks rushing to their doctor for a cholesterol check. Indeed, the findings are pretty scary. Study participants with the lowest HDL levels—defined as less than 40 mg/dL—were 53 percent more likely to perform poorly on short-term memory tests compared to those with high HDL, defined as 60 mg/dL or greater. (These healthy participants were age 61, on average, experiencing the earliest signs of dementia that typically start in middle age.) Those whose HDL levels plunged over the six-year study also experienced a decrease in the number of words they were able to recall on the memory test, says study leader Archana Singh-Manoux, senior research fellow in epidemiology at the University College London.
Video: Cholesterol: The Good and the Bad
Video: Cholesterol: The Good and the Bad

blog it


Subscribe to the Alzheimer's Reading Room
Email:

More Insight and Advice for Caregivers

Bob DeMarco is the Founder of the Alzheimer's Reading Room and an Alzheimer's caregiver. The blog contains more than 3,101 articles with more than 452,100 links on the Internet. Bob lives in Delray Beach, FL.

Creating Moments of Joy: A Journal for Caregivers, Fourth Edition

 

The 36-Hour Day A Family Guide to Caring for People with Alzheimer Disease



Original content Bob DeMarco, the Alzheimer's Reading Room

Flurizan’s Failure Leaves Key Alzheimer’s Theory Unresolved

clipped from blogs.wsj.com

Though Myriad Genetics was hoping its experimental Alzheimer’s drug Flurizan would surprise naysayers in the scientific and investment communities, the company instead announced that its Phase III clinical trial did indeed fail.

The company said Monday that the 18-month, 1,684-patient study – the largest Alzheimer’s-treatment study to date – showed Flurizan failed to improve cognitive functioning or activities of daily living, and added that Myriad is abandoning further efforts to develop the drug. This leaves Elan and Wyeth’s bapineuzumab and Eli Lilly’s gamma secretase inhibitor as the two leading candidates among disease-modifying Alzheimer’s drugs in development.
 blog it